|
|
|
Instructions,
|
Director Univ.-Prof.
Dr. rer.biol.hum. Uwe Heinrich Internet http://www.item.fraunhofer.de
Hannover, Additional Information Institute Renamed Dear Sir or Madam, During the past few years, the Fraunhofer ITA has built up two new
research and work areas: Drug Research and
Medical Biotechnology on the one hand, and Clinical Allergy, Asthma and Inhalation Research on the other hand.
The wide range of contract research and services has increasingly focused on the
investigation of effects and mechanisms of action by which environmental
pollutants and pharmaceuticals affect human health. The Institute’s old name did not convey this enhanced competency, and
the subtitle we have used so far was only an intermediate step on the way to a
modification of the Institute’s name. We have now accomplished this
modification: Starting in 2003, the name of the Fraunhofer Fraunhofer Institute of Toxicology
and Experimental Medicine (Fraunhofer ITEM). The
Department of Drug Research and Medical
Biotechnology is focused on molecular and mechanistic toxicology, molecular
medicine and in particular on pharmaco- and toxicogenomics. The focus of the Department of Clinical Allergy, Asthma and Inhalation Research are volunteer studies for clinical research and development, as well as environmental and workplace issues. The
area of Toxicology and Environmental
Hygiene, the well-established and internationally recognized focal point of
our research for more than 20 years, will continue to be one of our main
pillars, together with Aerosol Research.
The inhalation of substances and the respiratory tract as a primary target organ
will remain our priorities. All
these work areas of the Institute excellently complement each other in the
research of both intended and unwanted effects on human health. The
name has changed. What remains unchanged is our competency. Yours
sincerely,
Prof.
Dr. Uwe Heinrich Director |
